ORIGINAL RESEARCH article

Front. Behav. Neurosci., 15 April 2025

Sec. Emotion Regulation and Processing

Volume 19 - 2025 | https://doi.org/10.3389/fnbeh.2025.1570951

This article is part of the Research TopicStress, Mental Health, and the Synapse: Investigating the Mechanisms and ImplicationsView all 3 articles

Prenatal methadone exposure produces functional and molecular alterations in the basolateral amygdala and decreased voluntary ethanol intake in female, but not male offspring

  • 1Department of Psychology, Center for Development and Behavioral Neuroscience, Binghamton University, Binghamton, NY, United States
  • 2Developmental Exposure Alcohol Research Center, Binghamton, NY, United States

Introduction: A result of the ongoing opioid epidemic has been a significant rise in the rates of opioid use during pregnancy. This includes use of maintenance medications for opioid use disorder (MOUDs), such as methadone, which are the standard of care for pregnant people with an opioid use disorder (OUD). Although the use of MOUDs leads to better neonatal outcomes in exposed offspring compared to those born from individuals with untreated OUD, the pharmacology of MOUDs is similar to misused opioids. Despite the high prevalence of prenatal exposure to opioids, including MOUDs, our understanding of the long-term consequences of these exposures in offspring is limited. Prenatal drug exposure is known to be a risk factor for future substance use disorder and mood disorders, yet, how prenatal opioid exposure influences ethanol intake in adult offspring and associated affective behaviors has not been examined.

Methods: Using a rat model of prenatal methadone exposure (PME), which included twice daily methadone injections from gestational day 3-20, this study assessed ethanol intake in adult offspring and how exposure to forced swim stress (FSS) altered ethanol intake, in addition to examination of depressive-like behavior during the FSS. Given the role of the basolateral amygdala (BLA) in emotion and reward processing, we also conducted patch clamp electrophysiology experiments from BLA neurons to investigate changes in synaptic transmission and gene expression of neuromodulatory systems that are known to influence emotion and reward processing.

Results: Females with a history of PME consumed less ethanol than control females, with no effects of PME on ethanol intake evident in males. While PME increased immobility during FSS in both males and females, FSS had no effects on ethanol intake. PME increased glutamate transmission and altered dopamine D1, D2, and D3 receptor and mu opioid receptor mRNA in the BLA of females, but not in males.

Discussion: Collectively, this study identified impairments in emotion and reward processing, in addition to alterations in synaptic function and gene expression in the BLA of females with a history of PME, supporting previous findings from our lab demonstrating that female offspring are more sensitive to the long-term effects of PME.

Introduction

Opioid misuse and the incidence of opioid use disorder (OUD) has significantly risen over the past couple of decades (Spencer et al., 2024). Maintenance medications for OUD (MOUDs), such as methadone and buprenorphine, can facilitate abstinence and recovery from OUD, making this therapeutic an important form of harm reduction (Taylor et al., 2021). However, MOUDs are also approved and recommended for pregnant people with an OUD (Caritis and Panigrahy, 2019; Haight et al., 2018; Rodriguez and Klie, 2019), since there is an extensive literature supporting the use of MOUDs during pregnancy as a means to improve neonatal outcomes by reducing symptoms of Neonatal Opioid Withdrawal Syndrome (NOWS). Despite the beneficial effects of MOUDs, long-term consequences of MOUD use during pregnancy are concerning given that MOUDs are agonists at the same receptors that bind misused opioids. Evidence of this concern is becoming increasingly clear as there has been a rise in clinical and preclinical studies demonstrating potentially long-term effects of MOUDs in prenatally-exposed offspring (Aslaksen et al., 2024; Byrnes and Vassoler, 2018; Chen et al., 2015; Daly et al., 2012; Farid et al., 2008; Gamble and Diaz, 2023; Gamble et al., 2022; Hasan et al., 2024; Levine et al., 2021; Monnelly et al., 2019; Sahid et al., 2025; Spowart et al., 2023). While harm reduction is critical for pregnant people with OUD, there remains a large gap in our knowledge regarding the long-term effects of MOUD exposure in offspring.

Among long-term effects of prenatal opioid exposure, including exposure to MOUDs, increased addictive-related behaviors and negative affective behaviors have been reported repeatedly. In humans, a history of prenatal exposure to opioids is associated with increased emotional processing deficits, including anxiety and depression, as well as alterations in social behaviors (Baldacchino et al., 2014; Baldacchino et al., 2012; de Cubas and Field, 1993; Jaekel et al., 2021; Levine et al., 2021). Animal research demonstrates alterations in emotion processing evident in humans, for example, prenatal exposure to opioids, including MOUDs, increased anxiety-like behavior and reduced social interaction in rat offspring (Byrnes and Vassoler, 2018; Chen et al., 2015; Daly et al., 2012; Farid et al., 2008; Gamble and Diaz, 2023). Interestingly, prenatal opioid exposure of laboratory rodents has been shown to increase addiction-like behaviors to a variety of substances (see reviews Abu and Roy, 2021; Grecco and Atwood, 2020), including alcohol (Grecco et al., 2022a). Importantly, there is a well-established interplay between negative affect and addiction susceptibility, whereby negative affect can drive addiction-related behaviors, and vice-versa (Koob, 2015, 2022; Koob and Schulkin, 2019; Koob and Volkow, 2016). However, it is still unclear whether this relationship exists following prenatal opioid exposure. Importantly, knowledge of prenatal MOUD exposure effects may help guide targeted interventions to prevent the emergence of later substance misuse among affected offspring.

The basolateral amygdala (BLA) is involved in emotion and reward processing (Janak and Tye, 2015). Specifically, the BLA receives cortical and sensory inputs, which are locally processed and transmitted to downstream structures within the anxiety circuitry to drive both positive and negative emotions. Increased glutamatergic transmission within the BLA is hypothesized to drive BLA pyramidal neuron activity, which is correlated with negative affective behaviors, including anxiety and depression, as well as alterations in reward processing (Janak and Tye, 2015; Qin et al., 2021; Wassum and Izquierdo, 2015; Zhang et al., 2019; Zhang and Rosenkranz, 2012). Interestingly, there is recent evidence that human infants with prenatal opioid exposure showed increased functional connectivity between the amygdala and prefrontal cortex (Radhakrishnan et al., 2020) and smaller amygdalar volumes (Aslaksen et al., 2025), suggesting that the amygdala may be a target of prenatal opioid exposure contributing to impairments in emotion and reward processing. A recent preclinical study also identified alterations in amygdala activity in late-adolescent offspring with a history of prenatal methadone exposure (PME) (Grecco et al., 2022b). Despite these observations, long-term effects of prenatal opioid exposure on BLA function are not yet known.

Using a rat model of PME in which pregnant dams were exposed to 5–7 mg/kg twice daily on gestational days (G) 3–20, we recently reported that adult female PME offspring demonstrated heightened fear conditioning relative to control females, whereas male offspring were unaffected by PME (Gamble and Diaz, 2023). These female-specific effects were consistent with various other neurogenic, neurophysiological, and neurobehavioral alterations that we have previously reported (Gamble and Diaz, 2023; Gamble et al., 2022). Given our understanding of prenatal opioid exposure’s effects, particularly PME, the objective of the current study was to examine how PME affects (1) ethanol intake, (2) how later stress affects ethanol intake, (3) acute stress reactivity, and (4) BLA glutamatergic transmission in adult offspring. Additionally, we explored potential neuromodulatory systems within the BLA that may be disrupted by PME to identify potential mechanisms that may drive PME’s effects on BLA dysfunction and associated behavioral alterations.

Methods

Animals

Male and female Sprague–Dawley rats, originating from Envigo (Indianapolis, IN) were bred in-house. At weaning on postnatal day (P) 21, same-sex littermates were housed 2–3 per cage and randomly assigned to an experiment. Rats received 5L0D PicoLab Laboratory Rodent Diet and water ad libitum and were maintained on a 12 h light/dark cycle (lights on at 07:00). All procedures and protocols were in accordance with the National Institutes of Health guidelines for animal care using protocols approved by Binghamton University Institutional Animal Care and Use Committee.

Breeding and prenatal methadone exposure

Breeding and exposure procedures were identical to those described previously by our group (Gamble and Diaz, 2023; Gamble et al., 2022). Briefly, 2 drug naïve, nulliparous females and 1 male were housed together for up to 4 days. Daily vaginal swabs were conducted to detect the presence of sperm. Pregnancy was confirmed on the first day of detectable sperm, designated gestational day (G) 1, at which point the pregnant female was single-housed and randomly assigned to an exposure condition (control or methadone). Pregnant and lactating dams received Purina Lab Diet 5008C33 and water ad libitum. PME began on G3 with twice daily subcutaneous injections, 12 h apart (07:00 and 19:00), of 5 mg/kg of either methadone dissolved in sterile water (5 mg/mL solution) or sterile water alone (control group). From G4-20, the dose was increased to 7 mg/kg. Due to common side effects of methadone exposure in rats, particularly gnawing and pica, all dams (methadone and water-injected) were placed in a cage with no bedding (but with access to food and water) for 3 h following each injection to prevent ingestion of bedding and nesting material. Dams were returned to their home cages after 3 h until the next injection. 1% silver sulfadiazine topical cream was used to treat minor skin irritation due to injections where necessary. Dam weights were taken daily to determine administration volume; data on dam weight has been previously published (Gamble et al., 2022).

After the G20 exposure, dams were not disturbed and were allowed to give birth. After giving birth, pups were counted, weighed, and culled to 12 (equal male:female ratio) on P2. Pups were also weighed on P7 and P12, and were weaned on P21. Following weaning, offspring were allowed to age to adulthood (P70+) and randomized to an experiment; each experiment (voluntary ethanol intake/forced swim stress, electrophysiology, and PCR) was conducted in separate subsets of animals. Each experiment had no more than 2 pups per sex from the same litter.

Voluntary ethanol intake

A limited-access voluntary ethanol intake test was used to assess the effect of PME on ethanol consumption (control females = 7 litters; PME females = 5 litters; control males = 5 litters; PME males = 8 litters). As previously reported (Gamble and Diaz, 2020), ethanol intake sessions occurred every Monday, Wednesday, and Friday evening (19:00) for 3 weeks (total of 9 sessions). Briefly, animals were transported to a testing room, weighed, and placed in individual clean cages. A single drinking bottle containing sweetened ethanol solution (10% ethanol +3% sucrose +0.125% saccharin) was place on each cage for 30 min. The sweetened solution was used to increase palatability, consistent with previous methodologies for voluntary ethanol intake in rats (Broadwater et al., 2013; Walker et al., 2008). Drinking bottles were weighed before and after testing to calculate g/kg of ethanol consumed for each animal per session using the animals’ weight measured before each session. Daily intake was averaged per week and cumulative total intake over the 3 weeks was also calculated.

The final ethanol intake session was conducted on the 4th Monday as described above, 10–12 h after the forced swim stress (see below). See Figure 1 for a schematic depiction of the ethanol intake and forced swim stress time-course.

Forced swim stress

The Monday after the 3rd week of voluntary ethanol intake, rats underwent a single 10-min session of forced swim stress (FSS) in the morning at 08:00 as previously reported (Gamble and Diaz, 2020). Briefly, subjects were transported to the testing room and placed in individual polycarbonate cylinders (height = 45.72 cm, diameter = 20.32 cm) filled with water to 25 cm deep at 25°C. The 10 min sessions were video recorded for later scoring analysis. After the 10-min session, rats were dried with a towel and placed in a new cage for 30 min to allow further drying, and were then returned to their home cage and colony.

The 10-min FSS videos were scored by a blinded experimenter. Using the criteria discussed in Deak and Larish (2006), time to become immobile and total immobile time were calculated for each animal. Time to become immobile was defined as the seconds from when the animal entered the water to the time that they first became immobile, with immobility defined as the animal floating and only making minimal movements required to keep their head above water.

Drugs and chemicals

All chemicals used in electrophysiology and ethanol intake experiments were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise noted. Gabazine was purchased from Tocris/R&D Systems (Bristol, UK). Ethanol was purchased from Pharmco by Greenfield Global (Toronto, CA).

Whole cell patch-clamp electrophysiology

As previously described (Przybysz et al., 2017), using a different subset of animals (not behaviorally tested; control females = 7 litters; PME females = 8 litters; control males = 6 litters; PME males = 4 litters), P70-120 rats were anesthetized with 3% isoflurane and quickly decapitated. Brains were extracted and immersed in ice cold oxygenated (95% O2, 5% CO2) sucrose artificial cerebrospinal fluid (ACSF) cutting solution containing (in mM): sucrose (22), KCl (2), NaH2PO4 (1.3), NaHCO3 (26), glucose (10), MgSO4 (12), CaCl2 (0.2), and ketamine (0.43). 300 μm brain slices containing the BLA were made using a Vibratome (Leica Microsystems, Bannockburn, IL). Slices were incubated in oxygenated ACSF containing (in mM): NaCl (125), KCl (2), NaH2PO4 (1.3), NaHCO3 (26), glucose (10), MgSO4 (1), CaCl2 (2), and ascorbic acid (0.4) and allowed to recover for at least 40 min at 34°C before recording. Slices remained at 34°C and all experiments were performed within 4 h of slice preparation.

Following incubation, slices were transferred to a recording chamber superfused with oxygenated ACSF at 32°C at 3 mL/min. Recordings were made from pyramidal neurons within the BLA which were visualized using infrared-differential interference contrast microscopy (Olympus America, Center Valley, PA). Pyramidal neurons were visually identified based on morphology, and also neurophysiologically based on capacitance (>150 pF). Spontaneous excitatory postsynaptic current (sEPSC) recordings were collected with patch pipettes filled with K-gluconate internal solution, containing (in mM): K-gluconate (120), KCl (15), EGTA (0.1), HEPES (10), MgCl2 (4), Mg-ATP (4), Na-GTP (0.3), and phosphocreatine (7), with a pH of 7.3 and osmolarity of 295–305 mOsm. sEPSCs were pharmacologically isolated using the GABAA receptor antagonist gabazine (10 μM) while clamping the voltage at −70 mV. Neurons were allowed to equilibrate for at least 5 min before sEPSC recording began. We recorded at least 2 min of sEPSCs. Access resistance was monitored throughout each recording, and neurons with a >20% change in access resistance were excluded from analysis. Data were acquired with a MultiClamp 700B (Molecular Devices, Sunnyvale, CA) at 10 kHz, filtered at 1 kHz, and stored for later analysis using MiniAnalysis (Synaptosoft).

RNA extraction and real time RT-PCR

In a different subset of animals (not behaviorally test; control females = 4 litters; PME females = 4 litters; control males = 5 litters; PME males = 4 litters), rats were euthanized by rapid decapitation under deep anesthesia (3% isoflurane). Following decapitation, brains were quickly extracted and flash frozen in 2-methylbutane and stored at −80°C. The BLA was micro-punched in a cryostat and stored at −80°C until RNA extractions. Tissue punches were extracted with 500 μL Trizol ® RNA reagent and homogenized using Qiagen Tissue-Lyser II (Qiagen, Valencia, CA) for 2–4 min at 20 Hz to ensure sufficient homogenization of samples. Total cellular RNA was extracted using Qiagen RNeasy Mini Kits and separated from the supernatant using a chloroform extraction at 4°C. Equal volume of 70% ethanol was added to the collected RNA and purified through RNeasy mini columns. Columns were washed and eluted with 30 μL of RNase-free water (65°C). RNA yield and purity were determined using a NanoDrop 2000 spectrophotometer (NanoDrop, Wilmington, DE). RNA was stored at −80°C prior to cDNA synthesis. cDNA synthesis was conducted on 0.3–1.0 μg of normalized total RNA from each sample using QuantiTect Reverse Transcription kit (catalog # 205313, Qiagen, Valencia, CA), that included a DNase treatment step to remove any residual genomic DNA contamination. Probed cDNA amplification was performed in a 20 μL reaction and run in triplicate in a 384-well plate (BioRad Laboratories) using a RioRad CFX 384 Real Time System C1000 Thermal Cycler (BioRad Laboratories). Relative gene expression was quantified using the delta (2-ΔCT) method relative to the same-sex control. Because housekeeper genes often show fluctuation across experimental groups, we included GAPDH as a separate target gene to demonstrate stability of overall gene expression rather than formally treating GAPDH as a mathematically-adjusted “housekeeper” gene for greater transparency. Primer sequences are provided in Table 1.

Table 1
www.frontiersin.org

Table 1. Primer sequences used in real time RT-PCR.

Data analyses

Data were analyzed statistically using Prism (GraphPad, San Diego, CA). All data were tested for normal distribution; if data did not pass a test of normality, then non-parametric tests were used. Cumulative ethanol intake and FSS data was first analyzed as a 2-way ANOVA (exposure X sex). Similar to numerous previous studies (Mineur et al., 2022; Radke et al., 2021; Salazar and Centanni, 2024), we found a significant effect of sex in ethanol intake. Based on this, all data were separated by sex and analyzed using either a repeated 2-way ANOVA (exposure × week) for ethanol intake or t-test (exposure), electrophysiology, and mRNA expression. In the case of a significant interaction, Sidak’s post-hoc analyses were conducted to identify the locus of significance difference. For all statistical comparisons, p ≤ 0.05 was considered significant. All data are presented as mean ± SEM.

Figure 1
www.frontiersin.org

Figure 1. Experimental time-line for ethanol intake + forced swim stress (FSS) test in adult offspring. Testing age range was P70-120. Animals went through 3 weeks of 30 min limited-access voluntary ethanol intake sessions (10% ethanol +3% sucrose +0.125% saccharin) on Monday, Wednesday, and Friday at 19:00. On the Monday of the 4th week, all animals went through a FSS test ~09:00, followed by a final ethanol intake session at 19:00. Images were created using BioRender.

Results

PME reduced ethanol intake in females, but not males

To determine the effect of PME on voluntary ethanol intake, adult offspring went through 3 weeks of limited access ethanol intake sessions. Numerous studies have shown sex differences in ethanol intake in rodents, specifically that females consume more ethanol than males in a variety of ethanol intake paradigms (see recent reviews Mineur et al., 2022; Radke et al., 2021; Salazar and Centanni, 2024). Consistent with the extant literature, we found a significant effect of sex in cumulative ethanol intake over the 3 week period, whereby females consumed significantly more ethanol (Figure 2A: F (1, 34) = 28.20, p < 0.001), although there was no main effect of exposure (F (1, 34) = 3.448, p = 0.07) or an interaction (F (1, 34) = 0.156, p = 0.69). Given the large sex difference, we conducted a more detailed comparison in each sex to determine potential effects of PME as a function of week. Interestingly, in females, a 2-way ANOVA revealed a main effect of exposure (Figure 2B: F (1, 16) = 8.198, p < 0.05) and an exposure × week interaction (F (2, 32) = 5.07, p < 0.05), with a strong trend toward a main effect of week (F (2, 32) = 3.208, p = 0.054). Post-hoc analysis showed that PME females had a significantly lower ethanol intake than controls on week 3 (p < 0.01), with no significant differences evident on weeks 1 (p = 0.995) or 2 (p = 0.073). Conversely, in males there was no effect of exposure (F (1, 18) = 2.87, p = 0.11) nor an exposure × week interaction (F (2, 36) = 1.59, p = 0.21), although there was a strong trend toward a main effect of week (F (2, 36) = 3.189, p = 0.053), suggestive of a subtle increase in ethanol intake over the 3 weeks (Figure 2C).

Figure 2
www.frontiersin.org

Figure 2. Effects of PME on voluntary ethanol intake in adult offspring. (A) Cumulative ethanol intake across 3 weeks—main effect of sex (***p < 0.001) showed that females consumed significantly more ethanol than males. (B) Ethanol intake across 3 weeks (averaged by week) in females showed a significant effect of exposure (*p < 0.05) and exposure × week interaction (*p < 0.05); post-hoc analysis showed PME females had significantly lower ethanol intake relative to controls on week 3 (##p < 0.01). (C) No significant effects in male ethanol intake across 3 weeks (averaged by week). (D) Ethanol intake at baseline (week 3 average) and following FSS in females—no significant effect of stress, with a significant effect of exposure with reduced intake in PME females relative to controls (*p < 0.05). (E) No significant effect of stress or exposure in males.

PME increased immobility in a forced swim test

Increased negative affective behaviors, including reactivity to stress, have been reported in offspring with a history of PME. To examine potential effects of PME on acute stress reactivity, after the 3 weeks of voluntary ethanol intake, subjects were put through a single FSS test for 10 min. There was a trend for a significant difference in time to first instance of immobility as a function of exposure (F (1, 33) = 3.885, p = 0.057), with no effect of sex (F (1, 33) = 0.162, p = 0.69), or an interaction (F (1, 33) = 0.284, p = 0.60) (Figure 3A). Time was significantly higher in PME subjects relative to controls (main exposure effect: F (1, 33) = 5.718, p = 0.023) (Figure 3B). However, there was no sex difference (F (1, 33) = 0.003, p = 0.96) and no exposure × sex interaction (F (1, 33) = 0.189, p = 0.66). These findings suggest differences in response to acute stress in the FSS in PME offspring, independent of sex.

Figure 3
www.frontiersin.org

Figure 3. PME increased immobility time in the forced swim stress (FSS) test in adult offspring. (A) No effect of sex or exposure on time to first immobile episode. (B) PME significantly increased immobility time relative to controls (*p < 0.05), with no effect of sex.

Stress exposure did not affect ethanol intake

Exposure to stress can drive elevations in ethanol intake (Mineur et al., 2022), though these effects have been notoriously variable and depend upon the species tested, the timing and nature of the stress challenge imposed, and the approach for measuring ethanol intake (see Becker et al., 2011 for review). Given that prenatal opioid exposure, particularly PME, can disrupt neural responses to stress exposure, including reducing density of stress-neurons (i.e., corticotropin-releasing factor positive neurons) (Wu et al., 2023), we investigated whether exposure to FSS would differentially alter voluntary ethanol intake in PME offspring. Ten-twelve hours after FSS, subjects were given a single 30-min access ethanol intake session. Intake after FSS was compared to the average intake in week 3 (“baseline”). In females, we found a persistent main effect of exposure (F (1, 16) = 5.29, p = 0.03), with intake being significantly lower in PME females relative to controls (Figure 2D). However, there was no effect of stress (F (1, 16) = 0.408, p = 0.53) or an exposure × stress interaction (F (1, 16) = 0.004, p = 0.94). In contrast, males did not show an effect of exposure (F (1, 18) = 0.484, p = 0.49), stress (F (1, 18) = 2.17, p = 0.15), or interaction (F (1, 18) = 0.302, p = 0.59) (Figure 2E). These data indicate that FSS ~10 h prior to access to ethanol did not affect ethanol intake in either control or PME offspring. Furthermore, PME-induced reductions in ethanol intake in females persist despite exposure to stress.

PME increases BLA glutamate transmission only in females

The BLA is involved in emotion and reward processing (Janak and Tye, 2015). Given the behavioral changes resulting from PME, we next examined glutamatergic transmission within the BLA to begin to identify potential mechanisms that may drive the observed maladaptive behaviors. Neither membrane capacitance nor membrane resistance differed between control and PME males or females (Table 2). Interestingly, examination of glutamatergic transmission showed a significant increase in sEPSC frequency in PME females relative to controls (Figure 4A: t = 2.885, df = 22, p = 0.0086), but no difference in sEPSC amplitude (Figure 4B: t = 0.16, df = 22, p = 0.87). Conversely, neither sEPSC frequency (Figure 4C: t = 1.719, df = 14, p = 0.12) or amplitude (Figure 4D: Mann–Whitney U = 23, p = 0.39) differed between control and PME males. These findings suggest that PME increases glutamatergic transmission in adult females, without affecting adult males.

Table 2
www.frontiersin.org

Table 2. Membrane capacitance and resistance (mean ± SEM).

Figure 4
www.frontiersin.org

Figure 4. PME altered BLA glutamatergic transmission in females, but not males. PME significantly increased sEPSC (A) frequency (*p < 0.05), but not (B) amplitude in females—exemplar sEPSC traces from control and PME females (control: N = 7 animals, n = 13 cells; PME: N = 8 animals, n = 11 cells). PME did not affect sEPSC (C) frequency or (D) amplitude in males—exemplar sEPSC traces from control and PME males (control: N = 6 animals, 9 cells; PME: N = 5 animals, n = 7 cells).

PME altered BLA opioid and dopamine receptor gene expression in females only

We and others have shown that BLA function is modulated by endogenous opioid and dopamine systems through a variety of mechanisms (Diaz et al., 2011; Diaz et al., 2014; Przybysz et al., 2017; Yang et al., 2014). Additionally, chronic morphine exposure in juvenile male rats unmasks a D1R-mediated increase in glutamate transmission in BLA pyramidal neurons, an effect not apparent in controls (Li et al., 2011), whereas withdrawal from chronic heroin exposure downregulates D3R expression within the BLA of adult males (Rosen et al., 2017). Regarding the endogenous opioid system, exposure to prenatal morphine reduces mu-opioid receptor binding in the BLA (Vathy et al., 2003). To begin to identify potential mechanisms that may regulate BLA synaptic function and neurobehavioral alterations resulting from PME, we assessed expression of BLA mu opioid receptor (Oprm1), kappa opioid receptor (Oprk1), dopamine D1, D2, and D3 receptors (Drd1, Drd2, Drd3, respectively) and dopamine transporter (Dat) mRNA. There was no significant effect of PME on GAPDH in either sex, providing evidence for stable cellular gene expression patterns across experimental groups (Table 3 for statistics). Interestingly, we found a significant reduction in Oprm1 (Figure 5A: t = 3.100, df = 15, p = 0.007) and Drd3 (Figure 5E: t = 3.030, df = 15, p = 0.008) expression in PME females relative to control females (see Table 3 for statistics). We also found a significant increase in Drd1 (Figure 5C: t = 2.109, df = 15, p = 0.05) and Drd2 (Figure 5D: t = 2.093, df = 15, p = 0.05) in PME females compared to control females. There were no other significant differences in any of the other target genes in females (Oprk1 - Figure 5B, Dat - Figure 5F) nor in any of the target genes in males (see statistics in Table 3). Collectively, these findings suggest that PME dysregulates BLA gene expression of opioid and dopamine receptors exclusively in adult females.

Table 3
www.frontiersin.org

Table 3. Summary of statistics for opioid and dopamine receptor gene expression.

Figure 5
www.frontiersin.org

Figure 5. PME disrupted BLA gene expression in females, but not males. PME significantly decreased (A) Oprm1 (***p < 0.001) and (E) Drd3 (***p < 0.001) mRNA in females relative to controls. PME also significantly increased (C) Drd1 (*p < 0.05) and (D) Drd2 (*p < 0.05) mRNA in females relative to controls. PME did not affect (B) Oprk1 or (F) Dat mRNA in females or any of the genes in males.

Discussion

The primary goal of these studies was to determine whether PME might influence either baseline ethanol intake or stress-induced intake of ethanol, and the long-lasting neural consequences of PME. This is among one of the few studies investigating the long-term effects of PME on ethanol intake. The current study also assessed effects of PME on acute stress reactivity and cellular and molecular alterations within the BLA. In this study, we found that PME female offspring showed numerous alterations in all tested measures. Specifically, PME females consumed less ethanol than control females, in addition to showing increased immobility time in the FSS. Furthermore, BLA neurons from PME females had higher glutamatergic transmission, and there was dysregulation of gene expression for opioid and dopamine receptors within the BLA. Conversely, PME males only showed increased immobility time in the FSS test, but did not differ from control males in all other assessments. Collectively, these findings add to the growing literature demonstrating that PME leads to long-term alterations into adulthood and add further support to our previous observations that female offspring are particularly sensitive to PME’s effects.

Prenatal exposure to opioids may promote increased drug intake in offspring, thereby increasing the risk of substance use disorder (see reviews Abu and Roy, 2021; Grecco and Atwood, 2020). While various studies have tested effects of prenatal opioid exposure on future opioid or stimulant intake, whether prenatal opioid exposure alters future ethanol intake has only recently begun to be explored. One study by Grecco and Atwood found that pre-conception oxycodone exposure followed by PME in mice produced sex-specific effects on the rewarding properties of ethanol and ethanol intake in adolescent offspring (Grecco et al., 2022a). Specifically, PME males showed resistance to ethanol conditioned place preference, increased ethanol intake, and resistance to quinine-adulterated ethanol intake, while PME females exhibited enhanced sensitivity to the locomotor-stimulating effects of ethanol. Conversely, a different study reported that prenatal morphine exposure in rats did not affect ethanol intake (intermittent 2 bottle choice paradigm) in adolescent offspring (Parks et al., 2024), while unpublished work from Fleites and colleagues reported that prenatal morphine exposure in mice reduced ethanol intake (intermittent 2 bottle choice paradigm) in adult male offspring, but not female offspring (Fleites et al., 2022). Surprisingly, our findings indicate that PME reduced voluntary sweetened ethanol intake in a 30 min-limited access paradigm, but only in females. Furthermore, exposure to FSS ~10 h prior to the final drinking session did not affect ethanol intake, regardless of prenatal exposure. These findings were somewhat unexpected, since PME increased ethanol intake in adolescent offspring (Grecco et al., 2022a). However, it is possible that PME effects on ethanol intake may shift across development, as our findings are similar to those reported by Fleites and colleagues in prenatal morphine exposed offspring (Fleites et al., 2022). Although the mechanisms driving reduced ethanol intake in adult PME females are unknown, given that the ethanol solution was sweetened with sucrose and saccharin, it is possible that PME may produce anhedonia. While PME females showed increased immobility time during the FSS test compared to controls, which could suggest an increase in depressive-like behavior and support potential PME-induced anhedonia, it is worth noting that we used a single FSS session which has been suggested to reflect reactivity to stress more so than depressive-like behavior (Castagne et al., 2011). Thus, future studies should further assess this relationship and, in particular, how the sweetness of the ethanol solution plays a role in voluntary consumption. It is important to note that adult PME males also exhibited increased immobility time in the FSS test but had similar ethanol intake relative to control males; however, ethanol intake in all males was relatively low which may have prevented our ability to detect a further reduction in PME males. Another noteworthy difference between our study and that of Grecco and Atwood is the PME model. The PME model Grecco and Atwood used involved pre-conception exposure to oxycodone followed by a switch to methadone during the entire pregnancy with a higher dose of methadone (10 mg/kg) in mice, whereas our PME was limited to G3-20 with a max dose of 7 mg/kg in rats. Additionally, the assessment of ethanol intake differed between the two studies. Thus, there are several factors that may have contributed to differential effects on ethanol intake between the current study and the one by Grecco and Atwood. Regardless, given the limited number of studies testing the effects of prenatal opioid exposure on future ethanol consumption that, so far, have shown variable effects, there is a need for future studies examining this phenomenon.

One of the most interesting findings of the present study is that glutamate transmission was increased within the BLA of PME females relative to control females, with no differences evident in males. BLA pyramidal neuron activity has been correlated with anxiety-like behaviors (Wang et al., 2011), with infusion of glutamate antagonists into the BLA reducing anxiety-like behaviors (Lack et al., 2007). Thus, increased glutamate transmission in PME females could contribute to increased anxiety-like responses. In support of this, we previously found that adult PME females showed heightened freezing behavior across multiple extinction sessions in a contextual fear conditioning paradigm, whereas males did not exhibit these behaviors (Gamble and Diaz, 2023). It is possible that increased fear responding may be a result of a hyperactive BLA. As discussed above, PME females also had increased immobility time in the FSS test, which may indicate increased negative affective behaviors to which the BLA contributes. It is also interesting that only sEPSC frequency was increased in PME females, whereas sEPSC amplitude was not affected. Although there are many mechanisms that can contribute to the frequency of spontaneous neurotransmission, a change in frequency but not in amplitude may suggest a change in presynaptic function. There are numerous glutamatergic inputs into the BLA (see review Zhang et al., 2021), thus, it is possible that PME produces hyperexcitability of BLA inputs that may drive BLA activity. Future studies should further examine the impact of PME on other structures of the anxiety circuitry in addition to a more comprehensive investigation of the BLA microcircuitry. Importantly, the current study tested animals across a range of adulthood (P70-120) in order to align with the age of behavioral testing. Although it has been demonstrated that several neurophysiological mechanisms stabilize by P28 in the BLA (Ehrlich et al., 2013; Ehrlich et al., 2012), we acknowledge this may limit some interpretation of the data, and future studies should further examine if any age-related differences exist as a result of PME in the neurocircuitry assessed.

There are numerous neuromodulatory systems that regulate BLA function. Among these, the endogenous opioid and dopamine systems have been found to be a target of prenatal opioid exposure (Bhat et al., 2006; Darmani et al., 1992; Elam et al., 2022; Goetzl et al., 2019; Hou et al., 2004; McGinty and Ford, 1980; Robinson et al., 1997; Sarkaki et al., 2023; Wachman et al., 2018; Wang et al., 1986; Yazdanfar et al., 2021). Based on these studies, it is clear that there are numerous factors that influence the development of opioid and dopamine receptors, including the specific opioid exposure, timing of exposure, species, age of assessment, and brain region. Interestingly, our study found that PME females had reduced mRNA expression for the mu opioid receptor and dopamine D3 receptor, while also having increased mRNA levels for dopamine D1 and D2 receptors. We and others have previously shown that dopamine D1 and D3 receptors regulate GABA transmission in opposite ways in the BLA (Diaz et al., 2011; Diaz et al., 2014; Kroner et al., 2005), while dopamine D1 receptors modulate long-term potentiation within the BLA (Li et al., 2011). Dopamine inputs into the BLA also regulate anxiety-like behaviors in a variety of ways, depending on which dopamine receptor is activated or inhibited (Bananej et al., 2012; Brandao and Coimbra, 2019; Diaz et al., 2011; Zarrindast et al., 2011; Zhang et al., 2017). Mu opioid receptor activation within the BLA can both increase or decrease glutamate transmission depending on the mu receptor agonist used (i.e., morphine versus DAMGO) (Yang et al., 2014) and can regulate GABA transmission (Finnegan et al., 2006). Interestingly, BLA mu opioid receptors are involved in mediating motivation of cue-induced reward expectations (Lichtenberg and Wassum, 2017) and learning incentive values for food rewards (Wassum et al., 2011). Although our investigation into these neuromodulatory systems was only at the mRNA level, it is clear from our data that PME targets these two systems which may contribute to the observed changes in synaptic transmission and BLA-associated behavioral alterations. As with the behavioral and electrophysiological findings, it is quite interesting that the changes in gene expression were only observed in female offspring, while males did not show changes in any of the assessed genes. Nevertheless, it is important that future studies examine the impact of PME on opioid and dopamine systems within the BLA, both functionally and behaviorally, as this will elucidate the full extent of PME’s effects.

In conclusion, this is among the first studies to examine the long-term impact of PME on ethanol consumption. Additionally, this is also the first study that directly investigated PME effects on BLA physiology, which identified several potential mechanisms by which PME may produce maladaptive behaviors. Although PME reduced ethanol intake in adult female offspring, more studies are needed for assessment of PME effects on ethanol sensitivity and responsiveness later in life.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The animal study was approved by Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

MG: Data curation, Methodology, Writing – review & editing. MM: Data curation, Methodology, Writing – review & editing. DS: Data curation, Methodology, Writing – review & editing. TD: Writing – review & editing. EV: Funding acquisition, Writing – review & editing. MD: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by NIAAA grants R21AA030917, R21AA27873, R01AA028566, P50AA017823, and the Binghamton University’s Department of Psychology and Harpur Faculty Research Grant.

Acknowledgments

We would like to thank Allissa M. Parrella for her assistance with the PCR experiments.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Abu, Y., and Roy, S. (2021). Prenatal opioid exposure and vulnerability to future substance use disorders in offspring. Exp. Neurol. 339:113621. doi: 10.1016/j.expneurol.2021.113621

PubMed Abstract | Crossref Full Text | Google Scholar

Aslaksen, A. K., Bjuland, K. J., Hoem, M. L., Horgen, G., Haugen, O. H., Skranes, J., et al. (2025). Children had smaller brain volumes and cortical surface areas after prenatal opioid maintenance therapy exposure. Acta Paediatr. 114, 398–409. doi: 10.1111/apa.17448

PubMed Abstract | Crossref Full Text | Google Scholar

Aslaksen, A. K., Hoem, M. L., Vikesdal, G. H., Voie, M. T., Haugen, O. H., and Skranes, J. (2024). Children had increased risks of impaired motor and visual-motor skills after prenatal exposure to opioid maintenance therapy. Acta Paediatr. 113, 1331–1339. doi: 10.1111/apa.17175

PubMed Abstract | Crossref Full Text | Google Scholar

Baldacchino, A., Arbuckle, K., Petrie, D. J., and McCowan, C. (2014). Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry 14:104. doi: 10.1186/1471-244X-14-104

PubMed Abstract | Crossref Full Text | Google Scholar

Baldacchino, A., Balfour, D. J., Passetti, F., Humphris, G., and Matthews, K. (2012). Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci. Biobehav. Rev. 36, 2056–2068. doi: 10.1016/j.neubiorev.2012.06.006

PubMed Abstract | Crossref Full Text | Google Scholar

Bananej, M., Karimi-Sori, A., Zarrindast, M. R., and Ahmadi, S. (2012). D1 and D2 dopaminergic systems in the rat basolateral amygdala are involved in anxiogenic-like effects induced by histamine. J. Psychopharmacol. 26, 564–574. doi: 10.1177/0269881111405556

PubMed Abstract | Crossref Full Text | Google Scholar

Becker, H. C., Lopez, M. F., and Doremus-Fitzwater, T. L. (2011). Effects of stress on alcohol drinking: a review of animal studies. Psychopharmacology 218, 131–156. doi: 10.1007/s00213-011-2443-9

PubMed Abstract | Crossref Full Text | Google Scholar

Bhat, R., Chari, G., and Rao, R. (2006). Effects of prenatal cocaine, morphine, or both on postnatal opioid (mu) receptor development. Life Sci. 78, 1478–1482. doi: 10.1016/j.lfs.2005.07.023

PubMed Abstract | Crossref Full Text | Google Scholar

Brandao, M. L., and Coimbra, N. C. (2019). Understanding the role of dopamine in conditioned and unconditioned fear. Rev. Neurosci. 30, 325–337. doi: 10.1515/revneuro-2018-0023

PubMed Abstract | Crossref Full Text | Google Scholar

Broadwater, M., Varlinskaya, E. I., and Spear, L. P. (2013). Effects of voluntary access to sweetened ethanol during adolescence on intake in adulthood. Alcohol. Clin. Exp. Res. 37, 1048–1055. doi: 10.1111/acer.12049

Crossref Full Text | Google Scholar

Byrnes, E. M., and Vassoler, F. M. (2018). Modeling prenatal opioid exposure in animals: current findings and future directions. Front. Neuroendocrinol. 51, 1–13. doi: 10.1016/j.yfrne.2017.09.001

PubMed Abstract | Crossref Full Text | Google Scholar

Caritis, S. N., and Panigrahy, A. (2019). Opioids affect the fetal brain: reframing the detoxification debate. Am. J. Obstet. Gynecol. 221, 602–608. doi: 10.1016/j.ajog.2019.07.022

PubMed Abstract | Crossref Full Text | Google Scholar

Castagne, V., Moser, P., Roux, S., and Porsolt, R. D. (2011). Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. Chapter 8:Unit 8 10A. doi: 10.1002/0471142301.ns0810as55

Crossref Full Text | Google Scholar

Chen, H. H., Chiang, Y. C., Yuan, Z. F., Kuo, C. C., Lai, M. D., Hung, T. W., et al. (2015). Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats. Neuropsychiatr. Dis. Treat. 11, 609–618. doi: 10.2147/NDT.S70585

PubMed Abstract | Crossref Full Text | Google Scholar

Daly, F. M., Hughes, R. N., and Woodward, L. J. (2012). Subsequent anxiety-related behavior in rats exposed to low-dose methadone during gestation, lactation or both periods consecutively. Pharmacol. Biochem. Behav. 102, 381–389. doi: 10.1016/j.pbb.2012.05.010

PubMed Abstract | Crossref Full Text | Google Scholar

Darmani, N. A., Schnoll, S. H., Pandey, U., and Martin, B. R. (1992). Chronic prenatal methadone exposure alters central opioid mu-receptor affinity in both fetal and maternal brain. Neurotoxicol. Teratol. 14, 265–271. doi: 10.1016/0892-0362(92)90006-V

PubMed Abstract | Crossref Full Text | Google Scholar

de Cubas, M. M., and Field, T. (1993). Children of methadone-dependent women: developmental outcomes. Am. J. Orthopsychiatry 63, 266–276. doi: 10.1037/h0079429

PubMed Abstract | Crossref Full Text | Google Scholar

Deak, T., and Larish, Y. (2006). Methods and motives for use of the forced swim test as an animal model of behavioral despair/depression tasks and techniques: a sampling of the methodologies for the investigation of animal learning. Behav. Cogn., 3–18.

Google Scholar

Diaz, M. R., Chappell, A. M., Christian, D. T., Anderson, N. J., and McCool, B. A. (2011). Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 36, 1090–1103. doi: 10.1038/npp.2010.246

PubMed Abstract | Crossref Full Text | Google Scholar

Diaz, M. R., Jotty, K., Locke, J. L., Jones, S. R., and Valenzuela, C. F. (2014). Moderate alcohol exposure during the rat equivalent to the third trimester of human pregnancy alters regulation of GABAA receptor-mediated synaptic transmission by dopamine in the basolateral amygdala. Front. Pediatr. 2:46. doi: 10.3389/fped.2014.00046

PubMed Abstract | Crossref Full Text | Google Scholar

Ehrlich, D. E., Ryan, S. J., Hazra, R., Guo, J. D., and Rainnie, D. G. (2013). Postnatal maturation of GABAergic transmission in the rat basolateral amygdala. J. Neurophysiol. 110, 926–941. doi: 10.1152/jn.01105.2012

PubMed Abstract | Crossref Full Text | Google Scholar

Ehrlich, D. E., Ryan, S. J., and Rainnie, D. G. (2012). Postnatal development of electrophysiological properties of principal neurons in the rat basolateral amygdala. J. Physiol. 590, 4819–4838. doi: 10.1113/jphysiol.2012.237453

PubMed Abstract | Crossref Full Text | Google Scholar

Elam, H. B., Donegan, J. J., Hsieh, J., and Lodge, D. J. (2022). Gestational buprenorphine exposure disrupts dopamine neuron activity and related behaviors in adulthood. eNeuro 9:ENEURO.0499-21.2022. doi: 10.1523/ENEURO.0499-21.2022

PubMed Abstract | Crossref Full Text | Google Scholar

Farid, W. O., Dunlop, S. A., Tait, R. J., and Hulse, G. K. (2008). The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr. Neuropharmacol. 6, 125–150. doi: 10.2174/157015908784533842

PubMed Abstract | Crossref Full Text | Google Scholar

Finnegan, T. F., Chen, S. R., and Pan, H. L. (2006). Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels. J. Neurophysiol. 95, 2032–2041. doi: 10.1152/jn.01004.2005

PubMed Abstract | Crossref Full Text | Google Scholar

Fleites, V. C., Markwalter, P. S., Johnson, K., and De Biasi, M. (2022). In utero exposure to morphine leads to sex-specific behavioral alterations that persist into adulthood in cross-fostered mice. bioRxiv. doi: 10.1101/2022.02.28.482336

Crossref Full Text | Google Scholar

Gamble, M. E., and Diaz, M. R. (2020). Moderate adolescent ethanol vapor exposure and acute stress in adulthood: sex-dependent effects on social behavior and ethanol intake in Sprague-Dawley rats. Brain Sci. 10:829. doi: 10.3390/brainsci10110829

PubMed Abstract | Crossref Full Text | Google Scholar

Gamble, M. E., and Diaz, M. R. (2023). Prenatal methadone exposure leads to disruptions in adult-born dentate granule cell survival and female persistent fear responding. Addict. Neurosci. 8:100120. doi: 10.1016/j.addicn.2023.100120

PubMed Abstract | Crossref Full Text | Google Scholar

Gamble, M. E., Marfatia, R., and Diaz, M. R. (2022). Prenatal methadone exposure leads to long-term memory impairments and disruptions of dentate granule cell function in a sex-dependent manner. Addict. Biol. 27:27. doi: 10.1111/adb.13215

Crossref Full Text | Google Scholar

Goetzl, L., Thompson-Felix, T., Darbinian, N., Merabova, N., Merali, S., Merali, C., et al. (2019). Novel biomarkers to assess in utero effects of maternal opioid use: first steps toward understanding short- and long-term neurodevelopmental sequelae. Genes Brain Behav. 18:e12583. doi: 10.1111/gbb.12583

Crossref Full Text | Google Scholar

Grecco, G. G., and Atwood, B. K. (2020). Prenatal opioid exposure enhances responsiveness to future drug reward and alters sensitivity to pain: a review of preclinical models and contributing mechanisms. eNeuro 7:ENEURO.0393-20.2020. doi: 10.1523/ENEURO.0393-20.2020

Crossref Full Text | Google Scholar

Grecco, G. G., Haggerty, D. L., Reeves, K. C., Gao, Y., Maulucci, D., and Atwood, B. K. (2022a). Prenatal opioid exposure reprograms the behavioural response to future alcohol reward. Addict. Biol. 27:e13136. doi: 10.1111/adb.13136

PubMed Abstract | Crossref Full Text | Google Scholar

Grecco, G. G., Shahid, S. S., Atwood, B. K., and Wu, Y. C. (2022b). Alterations of brain microstructures in a mouse model of prenatal opioid exposure detected by diffusion MRI. Sci. Rep. 12:17085. doi: 10.1038/s41598-022-21416-9

PubMed Abstract | Crossref Full Text | Google Scholar

Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K., and Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. MMWR Morb. Mortal Wkly. Rep. 67, 845–849. doi: 10.15585/mmwr.mm6731a1

PubMed Abstract | Crossref Full Text | Google Scholar

Hasan, M., Meador, K. J., Brothers, T. N., Wang, S., Lewkowitz, A. K., Ward, K. E., et al. (2024). Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: a population-based study. Pharmacotherapy 44, 770–781. doi: 10.1002/phar.4616

PubMed Abstract | Crossref Full Text | Google Scholar

Hou, Y., Tan, Y., Belcheva, M. M., Clark, A. L., Zahm, D. S., and Coscia, C. J. (2004). Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling. Brain Res. Dev. Brain Res. 151, 149–157. doi: 10.1016/j.devbrainres.2004.05.002

PubMed Abstract | Crossref Full Text | Google Scholar

Jaekel, J., Kim, H. M., Lee, S. J., Schwartz, A., Henderson, J. M. T., and Woodward, L. J. (2021). Emotional and behavioral trajectories of 2 to 9 years old children born to opioid-dependent mothers. Res. Child Adolesc. Psychopathol. 49, 443–457. doi: 10.1007/s10802-020-00766-w

PubMed Abstract | Crossref Full Text | Google Scholar

Janak, P. H., and Tye, K. M. (2015). From circuits to behaviour in the amygdala. Nature 517, 284–292. doi: 10.1038/nature14188

PubMed Abstract | Crossref Full Text | Google Scholar

Koob, G. F. (2015). The dark side of emotion: the addiction perspective. Eur. J. Pharmacol. 753, 73–87. doi: 10.1016/j.ejphar.2014.11.044

PubMed Abstract | Crossref Full Text | Google Scholar

Koob, G. F. (2022). Anhedonia, Hyperkatifeia, and negative reinforcement in substance use disorders. Curr. Top. Behav. Neurosci. 58, 147–165. doi: 10.1007/7854_2021_288

PubMed Abstract | Crossref Full Text | Google Scholar

Koob, G. F., and Schulkin, J. (2019). Addiction and stress: an allostatic view. Neurosci. Biobehav. Rev. 106, 245–262. doi: 10.1016/j.neubiorev.2018.09.008

PubMed Abstract | Crossref Full Text | Google Scholar

Koob, G. F., and Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3, 760–773. doi: 10.1016/S2215-0366(16)00104-8

PubMed Abstract | Crossref Full Text | Google Scholar

Kroner, S., Rosenkranz, J. A., Grace, A. A., and Barrionuevo, G. (2005). Dopamine modulates excitability of basolateral amygdala neurons in vitro. J. Neurophysiol. 93, 1598–1610. doi: 10.1152/jn.00843.2004

PubMed Abstract | Crossref Full Text | Google Scholar

Lack, A. K., Diaz, M. R., Chappell, A., DuBois, D. W., and McCool, B. A. (2007). Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol. 98, 3185–3196. doi: 10.1152/jn.00189.2007

PubMed Abstract | Crossref Full Text | Google Scholar

Levine, T. A., Davie-Gray, A., Kim, H. M., Lee, S. J., and Woodward, L. J. (2021). Prenatal methadone exposure and child developmental outcomes in 2-year-old children. Dev. Med. Child Neurol. 63, 1114–1122. doi: 10.1111/dmcn.14808

PubMed Abstract | Crossref Full Text | Google Scholar

Li, C., Dabrowska, J., Hazra, R., and Rainnie, D. G. (2011). Synergistic activation of dopamine D1 and TrkB receptors mediate gain control of synaptic plasticity in the basolateral amygdala. PLoS One 6:e26065. doi: 10.1371/journal.pone.0026065

PubMed Abstract | Crossref Full Text | Google Scholar

Lichtenberg, N. T., and Wassum, K. M. (2017). Amygdala mu-opioid receptors mediate the motivating influence of cue-triggered reward expectations. Eur. J. Neurosci. 45, 381–387. doi: 10.1111/ejn.13477

PubMed Abstract | Crossref Full Text | Google Scholar

McGinty, J. F., and Ford, D. H. (1980). Effects of prenatal methadone on rat brain catecholamines. Dev. Neurosci. 3, 224–234. doi: 10.1159/000112395

PubMed Abstract | Crossref Full Text | Google Scholar

Mineur, Y. S., Garcia-Rivas, V., Thomas, M. A., Soares, A. R., McKee, S. A., and Picciotto, M. R. (2022). Sex differences in stress-induced alcohol intake: a review of preclinical studies focused on amygdala and inflammatory pathways. Psychopharmacology 239, 2041–2061. doi: 10.1007/s00213-022-06120-w

PubMed Abstract | Crossref Full Text | Google Scholar

Monnelly, V. J., Hamilton, R., Chappell, F. M., Mactier, H., and Boardman, J. P. (2019). Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis. Dev. Med. Child Neurol. 61, 750–760. doi: 10.1111/dmcn.14117

PubMed Abstract | Crossref Full Text | Google Scholar

Parks, B. J., Salazar, P., Morrison, L., McGraw, M. K., Gunnell, M., Tobacyk, J., et al. (2024). Limited bedding and nesting increases ethanol drinking in female rats. Pharmacol. Biochem. Behav. 239:173756. doi: 10.1016/j.pbb.2024.173756

PubMed Abstract | Crossref Full Text | Google Scholar

Przybysz, K. R., Werner, D. F., and Diaz, M. R. (2017). Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats. Neuropharmacology 117, 124–133. doi: 10.1016/j.neuropharm.2017.01.036

PubMed Abstract | Crossref Full Text | Google Scholar

Qin, X., Liu, X. X., Wang, Y., Wang, D., Song, Y., Zou, J. X., et al. (2021). Early life stress induces anxiety-like behavior during adulthood through dysregulation of neuronal plasticity in the basolateral amygdala. Life Sci. 285:119959. doi: 10.1016/j.lfs.2021.119959

PubMed Abstract | Crossref Full Text | Google Scholar

Radhakrishnan, R., Elsaid, N. M. H., Sadhasivam, S., Reher, T. A., Hines, A. C., Yoder, K. K., et al. (2020). Resting state functional MRI in infants with prenatal opioid exposure-a pilot study. Neuroradiology 63, 585–591. doi: 10.1007/s00234-020-02552-3

PubMed Abstract | Crossref Full Text | Google Scholar

Radke, A. K., Sneddon, E. A., Frasier, R. M., and Hopf, F. W. (2021). Recent perspectives on sex differences in compulsion-like and binge alcohol drinking. Int. J. Mol. Sci. 22:3788. doi: 10.3390/ijms22073788

PubMed Abstract | Crossref Full Text | Google Scholar

Robinson, S. E., Maher, J. R., Wallace, M. J., and Kunko, P. M. (1997). Perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the weanling rat. Neurotoxicol. Teratol. 19, 295–303. doi: 10.1016/S0892-0362(97)00018-4

PubMed Abstract | Crossref Full Text | Google Scholar

Rodriguez, C. E., and Klie, K. A. (2019). Pharmacological treatment of opioid use disorder in pregnancy. Semin. Perinatol. 43, 141–148. doi: 10.1053/j.semperi.2019.01.003

PubMed Abstract | Crossref Full Text | Google Scholar

Rosen, L. G., Rushlow, W. J., and Laviolette, S. R. (2017). Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 79, 59–66. doi: 10.1016/j.pnpbp.2017.06.009

PubMed Abstract | Crossref Full Text | Google Scholar

Sahid, A. S., Bebbington, M. J., Marcus, A., Baracz, S. J., Zimmermann, K. S., Oei, J., et al. (2025). Perinatal exposure to methadone or buprenorphine impairs hippocampal-dependent cognition and brain development in juvenile rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 137:111255. doi: 10.1016/j.pnpbp.2025.111255

PubMed Abstract | Crossref Full Text | Google Scholar

Salazar, A. L., and Centanni, S. W. (2024). Sex differences in mouse models of voluntary alcohol drinking and abstinence-induced negative emotion. Alcohol 121, 45–57. doi: 10.1016/j.alcohol.2024.07.004

PubMed Abstract | Crossref Full Text | Google Scholar

Sarkaki, A., Mard, S. A., Bakhtiari, N., and Yazdanfar, N. (2023). Sex-specific effects of developmental morphine exposure and rearing environments on hippocampal spatial memory. Int. J. Dev. Neurosci. 83, 178–190. doi: 10.1002/jdn.10245

PubMed Abstract | Crossref Full Text | Google Scholar

Spencer, M. R., Garnett, M. F., and Minino, A. M. (2024). Drug overdose deaths in the united sates, 2002–2022 : National Center for Health Statistics.

Google Scholar

Spowart, K. M., Reilly, K., Mactier, H., and Hamilton, R. (2023). Executive functioning, behavioural, emotional, and cognitive difficulties in school-aged children prenatally exposed to methadone. Front. Pediatr. 11:1118634. doi: 10.3389/fped.2023.1118634

PubMed Abstract | Crossref Full Text | Google Scholar

Taylor, J. L., Johnson, S., Cruz, R., Gray, J. R., Schiff, D., and Bagley, S. M. (2021). Integrating harm reduction into outpatient opioid use disorder treatment settings: harm reduction in outpatient addiction treatment. J. Gen. Intern. Med. 36, 3810–3819. doi: 10.1007/s11606-021-06904-4

PubMed Abstract | Crossref Full Text | Google Scholar

Vathy, I., Slamberova, R., Rimanoczy, A., Riley, M. A., and Bar, N. (2003). Autoradiographic evidence that prenatal morphine exposure sex-dependently alters mu-opioid receptor densities in brain regions that are involved in the control of drug abuse and other motivated behaviors. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27, 381–393. doi: 10.1016/S0278-5846(02)00355-X

Crossref Full Text | Google Scholar

Wachman, E. M., Hayes, M. J., Shrestha, H., Nikita, F. N. U., Nolin, A., Hoyo, L., et al. (2018). Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Genes Brain Behav. 17:e12476. doi: 10.1111/gbb.12476

Crossref Full Text | Google Scholar

Walker, B. M., Walker, J. L., and Ehlers, C. L. (2008). Dissociable effects of ethanol consumption during the light and dark phase in adolescent and adult Wistar rats. Alcohol 42, 83–89. doi: 10.1016/j.alcohol.2007.12.001

PubMed Abstract | Crossref Full Text | Google Scholar

Wang, C., Pasulka, P., Perry, B., Pizzi, W. J., and Schnoll, S. H. (1986). Effect of perinatal exposure to methadone on brain opioid and alpha 2-adrenergic receptors. Neurobehav. Toxicol. Teratol. 8, 399–402.

Google Scholar

Wang, D. V., Wang, F., Liu, J., Zhang, L., Wang, Z., and Lin, L. (2011). Neurons in the amygdala with response-selectivity for anxiety in two ethologically based tests. PLoS One 6:e18739. doi: 10.1371/journal.pone.0018739

Crossref Full Text | Google Scholar

Wassum, K. M., Cely, I. C., Balleine, B. W., and Maidment, N. T. (2011). Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward. J. Neurosci. 31, 1591–1599. doi: 10.1523/JNEUROSCI.3102-10.2011

PubMed Abstract | Crossref Full Text | Google Scholar

Wassum, K. M., and Izquierdo, A. (2015). The basolateral amygdala in reward learning and addiction. Neurosci. Biobehav. Rev. 57, 271–283. doi: 10.1016/j.neubiorev.2015.08.017

PubMed Abstract | Crossref Full Text | Google Scholar

Wu, C. Y., Chen, H. H., Tao, P. L., and Yuan, Z. F. (2023). Comparisons of stress-related neuronal activation induced by restraint in adult male rat offspring with prenatal exposure to buprenorphine, methadone, or morphine. Chin. J. Physiol. 66, 65–72. doi: 10.4103/cjop.CJOP-D-23-00015

PubMed Abstract | Crossref Full Text | Google Scholar

Yang, J., Yang, H., Du, X., Ma, Q., Song, J., Chen, M., et al. (2014). Morphine and DAMGO produce an opposite effect on presynaptic glutamate release via different downstream pathways of mu opioid receptors in the basolateral amygdala. Neuropharmacology 86, 353–361. doi: 10.1016/j.neuropharm.2014.08.021

PubMed Abstract | Crossref Full Text | Google Scholar

Yazdanfar, N., Farnam, A., Sadigh-Eteghad, S., Mahmoudi, J., and Sarkaki, A. (2021). Enriched environment and social isolation differentially modulate addiction-related behaviors in male offspring of morphine-addicted dams: the possible role of mu-opioid receptors and DeltaFosB in the brain reward pathway. Brain Res. Bull. 170, 98–105. doi: 10.1016/j.brainresbull.2021.02.005

PubMed Abstract | Crossref Full Text | Google Scholar

Zarrindast, M. R., Sroushi, A., Bananej, M., Vousooghi, N., and Hamidkhaniha, S. (2011). Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system. Eur. J. Pharmacol. 672, 106–112. doi: 10.1016/j.ejphar.2011.09.168

PubMed Abstract | Crossref Full Text | Google Scholar

Zhang, T., Chen, T., Chen, P., Zhang, B., Hong, J., and Chen, L. (2017). MPTP-induced dopamine depletion in basolateral amygdala via decrease of D2R activation suppresses GABA(a) receptors expression and LTD induction leading to anxiety-like behaviors. Front. Mol. Neurosci. 10:247. doi: 10.3389/fnmol.2017.00247

PubMed Abstract | Crossref Full Text | Google Scholar

Zhang, J. Y., Liu, T. H., He, Y., Pan, H. Q., Zhang, W. H., Yin, X. P., et al. (2019). Chronic stress remodels synapses in an amygdala circuit-specific manner. Biol. Psychiatry 85, 189–201. doi: 10.1016/j.biopsych.2018.06.019

PubMed Abstract | Crossref Full Text | Google Scholar

Zhang, W., and Rosenkranz, J. A. (2012). Repeated restraint stress increases basolateral amygdala neuronal activity in an age-dependent manner. Neuroscience 226, 459–474. doi: 10.1016/j.neuroscience.2012.08.051

PubMed Abstract | Crossref Full Text | Google Scholar

Zhang, W. H., Zhang, J. Y., Holmes, A., and Pan, B. X. (2021). Amygdala circuit substrates for stress adaptation and adversity. Biol. Psychiatry 89, 847–856. doi: 10.1016/j.biopsych.2020.12.026

Crossref Full Text | Google Scholar

Keywords: prenatal, methadone, opioid, basolateral amygdala, ethanol, stress

Citation: Gamble ME, Montero M, Silberstein DN, Deak T, Varlinskaya EI and Diaz MR (2025) Prenatal methadone exposure produces functional and molecular alterations in the basolateral amygdala and decreased voluntary ethanol intake in female, but not male offspring. Front. Behav. Neurosci. 19:1570951. doi: 10.3389/fnbeh.2025.1570951

Received: 04 February 2025; Accepted: 25 March 2025;
Published: 15 April 2025.

Edited by:

Jorge Sierra Fonseca, Chatham University, United States

Reviewed by:

Rodolfo Flores Garcia, National Institute of Mental Health (NIH), United States
Bryan Cruz, The Scripps Research Institute, United States

Copyright © 2025 Gamble, Montero, Silberstein, Deak, Varlinskaya and Diaz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marvin R. Diaz, bWRpYXpAYmluZ2hhbXRvbi5lZHU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.